A study of the secondary structure of ilamycin B1 by 300 MHz proton magnetic resonance  by Cary, Lewis W. et al.
Volume 17, number 1 FEBS LETTERS September 197 1 
A STUDY OF THE SECONDARY STRUCTURE OF ILAMYCIN B, 
BY 300 MHz PROTON MAGNETIC RESONANCE* 
Lewis W. CARY 
NMR Laboratories, Varian Associates, Palo Alto, Cali 94303, USA 
Tomohisa TAKITA 
Institute of Microbial Chemistry, Shinagawa-ku, Tokyo, Japan 
and 
Masako OHNISHI 
Department of Chemistry, Stanford University, Stanford, Calif: 94305, USA 
Received 27 May 1971 
Revised version received 12 July 1971 
1. Introduction 
Recent PMR and X-ray studies have shown that 
a common conformational feature of several cyclic 
polypeptide antibiotics is the P-turn associated 
with antiparallel pleated sheet structures [l-l 71. 
In PMR parameters, the p-turn is characterized by 
an amide proton resonance that is shifted to high 
field because of the magnetic anisotropy of the vi- 
cinal peptide moiety and has a low temperature 
coefficient due to intramolecular hydrogen bond- 
ing. Signals with a small c~-CHNH coupling con- 
stant reflecting the vicinal dihedral angle at the 
corner are also observed. 
The cyclic peptides tudied so far have an even 
number of residues, including a glycine or a D- 
amino acid which is energetically favored to form 
the corner of a &turn [ 16-201. The purpose of 
this study is to see if a cyclic peptide with an,odd 
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Space Administration, NASA NGL-05-020-250; National 
Institutes of Health, NIH GM-14752; Institutional Research 
Grant, American Cancer Society. 
number of residues and with only L-amino acids can 
have an antiparallel &type conformation. 
The cyclic peptide studied is ilamycin B1 , a cy- 
clic heptapeptide consisting of only Lamino acid 
residues (LiV-methyl eucine, Ltryptophan deri- 
vative, L-2-amino-tran&hexenoic acid, L-leucine, 
LN-methyl leucine, L-alanine and L3-nitrotyrosine). 
It is produced by Strepfomyces islandicus and is an 
analogue of ilamycin, an antibiotic inhibiting the 
growth of mycobacteria [2 l-231 . 
2. Experimental 
Material: Ilamycin B1 was obtained from Strepto- 
myces islandicus n. sp. and purified by a previously 
published procedure [23]. 0.06 M DMSO-d6 solu- 
tion was used for measurement. 
NMR equipment: Varian Associates’ 220 MHz 
and 300 MHz spectrometers with superconducting 
magnets, variable temperature, and tracked field 
sweep decoupling devices were used. The decoup- 
ling was done with a Wavetek VCO driven from the 
recorder sweep ot through a variable resistor net- 
work. 
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Fig. 1. 300 MHz Spectrum of ilamycin B1 in DMSOd6. 
3. Results 
The spectrum of ilamycin RI at 300 MHz in 
DMSO-d6 is shown in fig. 1. Five amide proton 
resonances are observed in the region 7.50-9.13 
ppm downfield from internal TMS. One of these 
is shifted to extremely high field and superim- 
posed on the tryptophan and 3nitrotyrosine ring 
proton resonances. The assignments indicated in 
the spectrum are based on results of the following 
decoupling experiments: The respective amide pro- 
ton resonances were linked with the correspond- 
ing (w-CH protons (the a-CHNH coupling constants 
are 6, 3,9 and 7.5 Hz from lower to higher field 
respectively for the four lower field resonances). 
Then all amide protons were exchanged by deu- 
terium to eliminate o-CHNH splitting. Decoup- 
ling between (w-CH and 2-CH protons was used to 
identify specific residues. Each &CH can be as- 
signed to a specific residue using the reference 
value of each amino acid and/or peptide derivative. 
The (r-CH resonances of alanine, the tryptophan 
derivative, 3nitrotyrosine, and 2-amino-trans- 
LCU CH3 
4-hexenoic acid were identified by this procedure. 
The remaining a-CH resonances of leucine and the 
two N-methyl leucines were assigned by the change 
in signal shape upon amide proton deuteration. The 
other assignments are indicated on the spectrum. 
Note that one of the three isopropyl methyl pro- 
tons of leucine residues is shifted to very high field 
at 0.43 and 0.27 ppm below TMS, whereas the other 
two appear around 0.9 ppm. 
The temperature dependence of amide proton 
chemical shifts (fig. 2) shows that the two upfield 
resonances are less temperature dependent, where- 
as the remaining three have the same dependence 
as the amide proton of N-methyl acetamide. This 
indicates that the amide protons of the 2-amino- 
trans4-hexenoic acid and 3nitrotyrosine residues 
are hydrogen bonded and form p-turns. Consistent 
with this interpretation is the hydrogen-deuterium 
exchange of the amide protons at room temperature 
in 10% D,O-DMSO. The order for exchange is 
1 > 2 3 3 > 5 > 4 (numbers are indicated on the 
spectrum): proton 1 exchanges within 2 hr, 2 takes 
3 hr, 3 takes several days, and 4 and 5 take much 
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Fig. 2. Temperature dependence of amide proton resonances 
for ilamycin B1 in DMSO-d6. NMA: N-methyl acetamide. 
NH*-H.A. : 2-NHz-trans-hexenoic acid. 
longer. The slow exchange of 4 and 5 is indicative 
of the rigid secondary structure, i.e., the hydrogen 
bonds, of the molecule. 
4. Discussion 
A proposed secondary structure of ilamycin Br 
is shown in fig. 3. All amide configurations are 
trans. There are P-turns with hydrogen bonding 
between the amide proton of 3nitrotyrosine and 
the carbonyl of 2-amino-trans-4-hexenoic acid and 
between the amide proton of the hexenoic acid 
and the carbonyl of alanine. One corner of the 
turn is occupied by the tryptophan derivative and 
an IV-Me-leucine; another N-Me-leucine and leucine 
are positioned at the other corner. The high field 
shift of one of the leucyl isopropyl methyl reso- 
nances can be explained from this structure in terms 
of the ring current effect of the indole ring of tryp- 
tophan or the nitrophenol ring (or both) depend- 
ing on the orientation of the side chains. The coup- 
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Fig, 3. A proposed secondary structure of ilamycin B,. 
ling constant between cr-CH and P-CH could not be 
observed because of overlapping of other signals, 
hence no information is available on the orienta- 
tion of these residues. 
The configurations of amide carbonyls other than 
those involved in hydrogen bonding may be inferred 
from steric considerations. The simple steric argument 
that the bulky side chain of the tryptophan deriva- 
tive at the beginning of the turn may prefer to be 
placed in an equatorial-like position suggests that 
the carbonyl between them points upward. More- 
over, this configuration suggests that the amide pro- 
ton [2] with the small coupling constant belongs 
to the tryptophan derivative residue due to the fol- 
lowing simple steric argument. When a bulky side 
chain is placed at the o-carbon at the beginning of 
the turn, empirically the coupling constant of the 
NHCH of the corner residue is small since the ap- 
proximately equatorial position of the group re- 
quires the dihedral angle of NH-CH to approach 
90”. A similar feature in the amide signal region 
was observed previously in the phenylalanine resi- 
due of gramicidin-S [7, 131 and the isoleucine of 
oxytocin derivatives [ 151. The same sort of argu- 
ment may be made for the other turn. But in this 
case, if the carbonyl at the amide linkage between 
N-Me-leucine and leucine is pointed down, not only 
is the amide hydrogen near the double bond region 
147 
Volume 17, number 1 FEBSLETTERS September 197 1 
of the hexenoic acid, but the leucine side chain 
between them is located in an approximately equa- 
torial position making the interaction sterically 
feasible. Such an interaction could cause the high 
field shift of this amide proton compared to the 
other nonhydrogen bonded protons [ 1,2] and 
slower rate of H-D exchange. The amide linkage 
between alanine and 3-nitrotyrosine which is not 
involved in either a &turn or a hydrogen bond can- 
not be predicted by such a preliminary observa- 
tion. One function of these residues may be to 
ease the steric crowding. 
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